Toll‐like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of <scp>SE</scp> ‐induced epilepsy in mice

Abstract

This study reveals novel insights into the pathophysiology of epilepsy and the contribution of TLR3 to disease progression. Our results identify the TLR3 pathway as a potential future therapeutic target in SE.